Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Amgen Inc.

Market Cap 184B 161B 148B 139B 261B 17,379B 262B 1,762B 684B 8,564B 692B 677B 29,684B P/E 2026 *
22.2x
P/E 2027 * 20.2x
Enterprise Value 226B 197B 181B 170B 319B 21,265B 321B 2,156B 837B 10,479B 847B 829B 36,322B EV / Sales 2026 *
5.97x
EV / Sales 2027 * 5.67x
Free-Float
99.78%
Yield 2026 *
2.95%
Yield 2027 * 3.12%
1 day-2.08%
1 week-5.41%
Current month-0.56%
1 month+3.24%
3 months-4.72%
6 months+3.23%
Current year+2.32%
1 week 334.2
Extreme 334.2
358.3
1 month 320.96
Extreme 320.965
358.46
Current year 318.21
Extreme 318.21
391.29
1 year 267.83
Extreme 267.83
391.29
3 years 218.44
Extreme 218.44
391.29
5 years 198.64
Extreme 198.64
391.29
10 years 133.64
Extreme 133.64
391.29
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 67 01/01/2020
Chief Operating Officer 59 25/07/2016
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Date Insider Type Main position Quantity % Market Cap.
05-19Free

Director

665 0.0001%
05-19Free

Director

665 0.0001%
05-19Free

Director

665 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-5.41%+15.63%+46.50% 184B
-0.93%-5.20%+40.20%+143.52% 992B
-1.90%-3.72%+52.23%+39.80% 564B
-2.11%-3.71%+16.69%+57.05% 391B
-2.90%+0.68%+24.66%+16.53% 330B
-2.36%-3.12%+24.71%+12.95% 280B
-2.45%-2.88%+24.29%+29.93% 279B
-1.91%-0.87%-41.95%-48.26% 196B
-2.11%-2.41%+13.72%+58.05% 156B
-2.60%-3.65%+5.59%-35.90% 148B
Average -2.22%+0.50%+17.58%+32.02% 351.9B
Weighted average by Cap. -1.94%-0.42%+27.07%+58.92%

Financials

2026 *2027 *
Net sales 37.79B 32.92B 30.35B 28.55B 53.41B 3,561B 53.78B 361B 140B 1,755B 142B 139B 6,083B 38.73B 33.75B 31.11B 29.26B 54.75B 3,651B 55.13B 370B 144B 1,799B 145B 142B 6,236B
Net income 8.26B 7.2B 6.64B 6.24B 11.68B 779B 11.76B 78.98B 30.67B 384B 31.02B 30.36B 1,330B 9.04B 7.88B 7.26B 6.83B 12.78B 852B 12.87B 86.39B 33.55B 420B 33.93B 33.21B 1,455B
Net Debt 41.23B 35.93B 33.12B 31.15B 58.28B 3,886B 58.69B 394B 153B 1,915B 155B 151B 6,638B 35.08B 30.57B 28.18B 26.5B 49.58B 3,306B 49.93B 335B 130B 1,629B 132B 129B 5,648B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
18/06/26 334.92 $ -1.97% 2,214,697
17/06/26 341.66 $ -1.78% 3,470,311
16/06/26 347.84 $ -0.77% 3,516,790
15/06/26 350.53 $ -1.31% 4,371,390
12/06/26 355.20 $ +0.32% 2,730,230
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
341.66USD
Average target price
352.17USD
Spread / Average Target
+3.08%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMGN Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!